relapsed/refractory her2 mbc: evolving treatment landscape
Published 4 years ago • 57 plays • Length 3:04Download video MP4
Download video MP3
Similar videos
-
3:44
relapsed/refractory her2 mbc: future treatment landscape
-
6:29
evolving treatment landscape of r/r her2 mbc
-
6:23
treatment strategies for relapsed/refractory her2 mbc
-
6:28
evolving treatment landscape of r/r her2 mbc
-
19:20
fda-approved therapies for relapsed/refractory her2 mbc
-
8:47
what's new in breast cancer treatment in 2023 | top breast cancer docs discuss emerging research
-
20:11
her2-positive breast cancer—reduce your risk of recurrence | access health
-
4:11
what is her2 positive breast cancer? | treatment/therapies for her2 positive breast cancer
-
1:44
dr. tripathy on the evolving treatment landscape of her2 breast cancer
-
4:44
treatments for relapsed/refractory her2 breast cancer
-
4:12
optimizing treatment in patients with early-stage her2-positive breast cancer
-
2:17:54
changing treatment landscape in hr her2 abc
-
0:45
the evolution of her2-low breast cancer from primary to recurrence
-
4:37
changing treatment landscape in metastatic breast cancer
-
0:30
the role of serds in the treatment landscape of patients with er /her2- breast cancer
-
30:57
treatment updated for her2 positive breast cancer: changing paradigms
-
1:12
dr. yorio on t-dm1 in her2-mutant lung cancer treatment
-
6:06
combining anti-her2 agents with immunotherapy for her2 mbc
-
3:48
her2 breast cancer: future treatment landscape
-
2:53
unmet needs in the management of her2 mbc
-
6:46
neratinib in mbc with her2 activating mutations
-
54:02
navigating shifts in the treatment landscape for metastatic her2-positive breast cancer